Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Masitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science gets Chinese patent for masitinib in Covid-19
    AB Science gets Chinese patent for masitinib in Covid-19

    19 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/19/3083680/0/en/AB-Science-receives-Chinese-patent-protecting-masitinib-in-the-treatment-of-Covid-19-until-2041-adding-one-more-indication-with-long-term-intellectual-property-protection.html

    GLOBENEWSWIRE
    19 May 2025
    Share Share
    AB Science: PLOS One Publishes Masitinib Neuroprotective Data
    AB Science: PLOS One Publishes Masitinib Neuroprotective Data

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3081812/0/en/AB-Science-today-reports-a-new-publication-in-the-scientific-journal-PLOS-One-showing-promising-neuroprotective-effects-of-masitinib.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    AB Science gets US patent for masitinib until 2040 for sickle cell
    AB Science gets US patent for masitinib until 2040 for sickle cell

    14 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/14/3061150/0/en/AB-Science-receives-notice-of-allowance-for-Unites-States-patent-covering-masitinib-until-2040-in-the-treatment-of-sickle-cell-disease.html

    GLOBENEWSWIRE
    14 Apr 2025
    Share Share
    AB Science: Life Sciences Magazine Features Masitinib, Dr. Vermersch
    AB Science: Life Sciences Magazine Features Masitinib, Dr. Vermersch

    04 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/04/3036186/0/en/AB-Science-Article-from-the-leading-publication-Life-Sciences-Magazine-featuring-masitinib-and-its-Phase-3-principal-investigator-the-neurologist-Patrick-Vermersch.html

    GLOBENEWSWIRE
    04 Mar 2025
    Share Share
    AB Science today provides an update on its masitinib platform
    AB Science today provides an update on its masitinib platform

    29 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/29/3017503/0/en/AB-Science-today-provides-an-update-on-its-masitinib-platform.html

    GLOBENEWSWIRE
    29 Jan 2025
    Share Share
    AB Science Updates On Masitinib In Multiple Sclerosis
    AB Science Updates On Masitinib In Multiple Sclerosis

    23 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/23/2951617/0/en/AB-Science-provides-an-update-on-the-development-of-masitinib-in-progressive-forms-of-multiple-sclerosis-post-ECTRIMS-2024.html

    GLOBENEWSWIRE
    23 Sep 2024
    Share Share